Close Menu

NEW YORK (GenomeWeb) – Swiss startup Scailyte announced yesterday that it has raised CHF 2.8 million (US $2.8 million) in a seed funding round.

The Luzern, Switzerland-based firm will use the capital to improve market entry and to expedite development of ScaiVision, an artificial intelligence-based software that analyzes single-cell data to enhance biomedical research, pharmaceutical discovery, and precision diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.